Language as a barrier to cancer clinical trial accrual: assessing consenting team knowledge and practices for cancer clinical trial consent among low English fluency patients

Table 1 Rates of Correct Responses to Study Survey

	Entire Cohort		Nurses/CRC		PIs/Co-PIs		p-value
	(N = 53)		(N = 31)		(N = 22)		p-value
Scenario 1	26/53	49%	19/31	61%	7/22	32%	0.0514
Scenario 2a	21/46	46%	17/28	61%	4/18	22%	0.0156*
Scenario 2b	23/45	51%	17/27	63%	6/18	33%	0.0715
Scenario 2c	22/46	48%	18/28	64%	4/18	22%	0.0072*
Scenario 3	34/44	77%	21/26	81%	13/18	72%	0.7161
Question 1	30/44	68%	21/26	81%	9/19	50%	0.0489*
Question 2	44/45	98%	26/27	96%	18/18	100%	0.9999
Question 3	36/45	80%	22/27	81%	14/18	78%	0.9999
Total Score	(n = 45)		(n = 27)		(n = 18)
Total Score	64.8 +/− 24.6		73.8 +/− 20.5		51.4 +/− 24.6		0.0033*

Abbreviations: (CRC) Clinical Research Coordinator, (PI) Principle Investigator
* Indicates Nurses/CRC group is significantly greater than PIs/Co-PIs (p < 0.05)